April 6, 2022
Now available CAMCEVI™
CAMCEVI™ (leuprolide) injectable emulsion, for subcutaneous use, is a gonadotropin-releasing hormone (GnRH) agonist indicated for the treatment of adult patients with advanced prostate cancer.
April 6, 2022